AU2576877A - Hydantoin derivatives - Google Patents

Hydantoin derivatives

Info

Publication number
AU2576877A
AU2576877A AU25768/77A AU2576877A AU2576877A AU 2576877 A AU2576877 A AU 2576877A AU 25768/77 A AU25768/77 A AU 25768/77A AU 2576877 A AU2576877 A AU 2576877A AU 2576877 A AU2576877 A AU 2576877A
Authority
AU
Australia
Prior art keywords
hydantoin derivatives
hydantoin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU25768/77A
Other versions
AU515174B2 (en
Inventor
A. G. and Whittaker N Caldwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU2576877A publication Critical patent/AU2576877A/en
Application granted granted Critical
Publication of AU515174B2 publication Critical patent/AU515174B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU25768/77A 1976-06-03 1977-06-02 Hydantoin derivatives Expired AU515174B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB22877/76 1976-06-03
GB2287776 1976-06-03

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU47625/79A Addition AU4762579A (en) 1978-05-31 1979-05-30 Hydantoin derivatives

Publications (2)

Publication Number Publication Date
AU2576877A true AU2576877A (en) 1978-12-07
AU515174B2 AU515174B2 (en) 1981-03-19

Family

ID=10186483

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25768/77A Expired AU515174B2 (en) 1976-06-03 1977-06-02 Hydantoin derivatives

Country Status (3)

Country Link
AU (1) AU515174B2 (en)
BE (1) BE855337A (en)
ZA (1) ZA773324B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531493B2 (en) * 1977-12-01 1983-08-25 The Wellcome Foundation Limited Thiohydantion derivatives

Also Published As

Publication number Publication date
BE855337A (en) 1977-12-02
AU515174B2 (en) 1981-03-19
ZA773324B (en) 1979-01-31

Similar Documents

Publication Publication Date Title
AU509754B2 (en) Benazepine derivatives
AU517585B2 (en) Phenoxybenzyloxycarbonyl derivatives
AU507258B2 (en) Fluoroacacylresorcin derivatives
AU504526B2 (en) Pipeazine derivatives
AU517829B2 (en) Morphanthridine derivatives
AU514523B2 (en) Hydantoin and thio-hydantoin derivatives
AU502122B2 (en) 5-0-acylated-imidazole-4-carboxamide derivatives
AU527959B2 (en) Hydantoin derivatives
AU515192B2 (en) Quinoxaline-din-oxide derivatives
AU517512B2 (en) Imidazole derivatives
AU514770B2 (en) Imidazole derivatives
AU512647B2 (en) Solpenamide derivatives
AU513069B2 (en) 17-spirosiltine derivatives
AU514803B2 (en) 4-phenylpipridine derivatives
AU507708B2 (en) Hydrazino-pyridazine derivatives
AU515174B2 (en) Hydantoin derivatives
AU505150B2 (en) Triazolobenzazepine derivatives
AU503490B2 (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU519085B2 (en) 1-carba-2-penem derivatives
AU511948B2 (en) Nortropine-carbazate derivatives
AU1858676A (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU515135B2 (en) Ribofuranosyl-imidazole derivatives
AU508555B2 (en) 6-carboxy-flavone derivatives
AU540464B2 (en) Morphanthridine derivatives
AU512688B2 (en) Thienyl-and T-aminophenyl-pyrrolidine derivatives